Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 102,050 | 45,720 | 82,830 | 148,230 | 92,214 |
Marketable Securities | 13,860 | 26,920 | 32,100 | 62,810 | 26,038 |
Receivables | 180,860 | 97,220 | 65,040 | 27,150 | 25,081 |
Inventories | 108,530 | 78,780 | 46,960 | 23,210 | 22,637 |
Other current assets | 29,410 | 44,610 | 19,830 | 18,190 | 31,664 |
TOTAL | $434,710 | $293,250 | $246,760 | $279,590 | $197,634 |
Non-Current Assets | |||||
PPE Net | 138,840 | 109,130 | 88,000 | 73,590 | 69,999 |
Investments And Advances | 291,440 | 193,150 | 131,080 | 61,160 | 49,355 |
Other Non-Current Assets | 573,740 | 474,500 | 289,120 | 5,240 | 5,133 |
TOTAL | $1,004,020 | $776,780 | $508,200 | $139,990 | $124,487 |
Total Assets | $1,438,750 | $1,070,040 | $754,980 | $419,590 | $322,121 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 1,690 | 980 | 860 | 670 | 622 |
Accounts payable and accrued liabilities | 56,480 | 63,790 | 44,420 | 20,200 | 25,215 |
Other current liabilities | 37,450 | 30,000 | 45,000 | 0 | 0 |
TOTAL | $129,180 | $94,780 | $99,840 | $21,350 | $28,822 |
Non-Current Liabilities | |||||
Long Term Debt | 149,500 | 149,870 | 2,380 | 2,900 | 3,577 |
aiOther Non-Current Liabilities | 18,440 | 20,400 | 50,850 | 400 | 687 |
TOTAL | $255,000 | $224,780 | $90,110 | $15,520 | $4,264 |
Total Liabilities | $384,190 | $319,560 | $189,970 | $36,880 | $33,086 |
Shareholders' Equity | |||||
Common Shares | 310 | 290 | 290 | 120 | 120 |
Retained earnings | 549,000 | 395,860 | 275,030 | 216,000 | 142,711 |
Other shareholders' equity | 107,540 | 60,650 | 33,010 | 7,200 | -235 |
TOTAL | $1,054,550 | $750,470 | $565,010 | $382,710 | $289,035 |
Total Liabilities And Equity | $1,438,740 | $1,070,030 | $754,980 | $419,590 | $322,121 |